Genesco

GCO · NYSE

$36.63+$0.16 (+0.44%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $36.47

GCO analyst rating

HoldConsensus of 2 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold2
Underperform0
Sell0

12-month price target · 4 analysts

Average $40.46 (+10.5% upside)

Low: $36.36
Now: $36.63
High: $47.25

Upgrades and downgrades

The latest rating actions, newest first

GCO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Truist Securities	Sep 4, 2026	Maintains	Hold	$40.00 → $38.00	21%
Seaport Global	May 27, 2026	Downgrade	Buy → Neutral	—	55%
Truist Securities	Mar 9, 2026	Maintains	Hold	$38.00 → $32.00	21%
Truist Securities	Dec 5, 2025	Maintains	Hold	$31.00 → $27.00	21%

The case for and against

Updated Oct 18, 2026

Bull case

Genesco is supported by improving profitability at Journeys, where 2Q comps rose 2% and 3QTD comps accelerated to the mid-single digits, driven by stronger full-priced sales, athletic lifestyle and low-profile styles, and 4.0 remodels that reportedly lift sales by more than 25%. The company is also showing better operating leverage, with Journeys delivering about 180 basis points of expense leverage despite roughly flat sales, while management continues to expand the remodel footprint, target 95 remodels this year, and close unproductive stores to sharpen execution. Johnston & Murphy adds to the bullish case with 4% 2Q comps, rising brand awareness, and double-digit new-customer revenue growth, while FY27 EPS is expected to improve materially from $1.45 last year to $1.90-$2.30 on gross margin expansion and better earnings momentum.

Bear case

Genesco is facing a softer fundamental backdrop as weakening consumer spending, higher gas prices, and broader macroeconomic pressure are expected to reduce sales growth and weigh on margins, with 1Q27 guided to lower sales and EBIT/EPS versus a year ago. The outlook is further pressured by mall traffic headwinds that could slow Journeys’ turnaround, while schuh appears vulnerable to a weaker UK consumer and less confidence in lower operating losses despite cleaner inventory. Tariff costs, inability to fully pass through product inflation, and store and license exits creating about a $30MM sales drag each add to the risk of earnings disappointment, even as FY27 guidance still implies only slight comp growth on $2.412B-$2.436B of sales.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.